Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidiol as a New Treatment for Cocaine Addiction

NCT02559167 is registered in ClinicalTrials.gov with Centre hospitalier de l'Université de Montréal (CHUM) as lead sponsor.

NCT NCT02559167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02559167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidiol as a New Treatment for Cocaine Addiction
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2016
Completion date
August 16, 2019
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine dependence, substance use disorder, withdrawal from addictive substance; detoxification